One monoclonal antibody treatment used at many U.S. hospitals

The FDA has pulled emergency use authorization for Regeneron and Eli Lilly's antibody drugs, saying they did not work against the Omicron variant, leaving Sotrovimab as the only monoclonal treatment being used at many hospitals across the nation.